Economic Impact of Early Disease Detection

resource-image

The Integrated Benefits Institute presents groundbreaking research that definitively answers a critical question for employers: Does early disease detection in workplace health programs deliver measurable economic value? Our comprehensive systematic review of 61 studies spanning 25 years provides clear evidence that the answer is a resounding yes.

Key Research Findings

This analysis examined early detection programs across six major chronic diseases affecting working populations: cardiovascular disease, diabetes, COPD, rheumatoid arthritis, chronic kidney disease, and non-alcoholic fatty liver disease. The results are striking:

• 100% positive economic outcomes: Not a single study reported negative economic returns from early detection programs
• $1,300-$3,000 annual cost savings per patient across disease categories
• ROI achieved within 2-3 years for most workplace programs
• Dual benefit stream: Both direct medical cost reductions and productivity improvements

View Report
Tags: Absence management, Research Report